Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Samsung Biologics Obtains Four Global ISO Certifications | Contract Pharma

Samsung Biologics Obtains Four Global ISO Certifications

Meets rigorous requirements for drug substance and drug product.

Samsung Biologics, a CDMO, has obtained four global ISO certifications: ISO22301 (Business Continuity Management), ISO50001 (Energy Management), ISO45001 (Occupational Health and Safety Management), and ISO14001 (Effective Environmental Management) from the British Standards Institution (BSI).
    
Upon meeting rigorous requirements and standards for ISO certification, the updated BCMS, ISO22301:2019, was awarded to Samsung Biologics’ Contract Development Organization (CDO) along with recertification for existing business areas, including Drug Substance and Drug Product, which was first certified in April 2018. Samsung Biologics is the first company to have earned the latest BCMS certification in South Korea and will now be qualified with the international accreditation across all of its business areas.

“We are extremely proud to obtain four global ISO certifications during a time where a high degree sustainable management system is vital, especially in light of COVID-19, to stably operate and supply crucial biomedicines for patients,” John Rim, CEO of Samsung Biologics, commented. “Samsung Biologics is a leading CDMO committed to taking responsibility and consideration of ESG factors across all of our business areas, and we will continue to enhance our capabilities to meet the evolving needs of clients whilst ensuring the safety and security of not only our people but also of the environment to ultimately create a better future for humanity.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters